Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2003
09/04/2003US20030166073 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
09/04/2003US20030166045 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant
09/04/2003US20030166044 Novel proteins
09/04/2003US20030166016 Assay methods for cyclin dependent kinases
09/04/2003US20030165892 Unigene unidirectional antisense library
09/04/2003US20030165874 Nucleotide sequences probes for diagnosing and treating seizure disorders; restriction fragment length polymorphisms
09/04/2003US20030165809 MARKs as modifiers of the p53 pathway and methods of use
09/04/2003US20030165589 Plant extract of the species <I>vitis vinifera <I> as no-synthase inhibitor and uses
09/04/2003US20030165588 Cyclooxygenase inhibitors; antiinflammatory drugs
09/04/2003US20030165576 Antitumor effect potentiators
09/04/2003US20030165561 Substituted diphenyl heterocycles useful for treating HCV infection
09/04/2003US20030165552 Compositions and methods for delivery of skin cosmeceuticals
09/04/2003US20030165548 Process for producing functional silk fibroin and utilization of the same
09/04/2003US20030165503 Vaccine for the treatment of atherosclerosis
09/04/2003US20030165494 Rheumatic diseases; anticholesterol agents; cardiovascular disorders; multiple sclerosis
09/04/2003US20030165464 In vivo stimulation of angiogenic activity
09/04/2003US20030165462 Deleted adenovirus vectors and methods of making and administering the same
09/04/2003US20030165460 Proteins which control cell differentiation; immunology response; antiinflammatory agents; wound healing agents
09/04/2003US20030165449 Lipase inhibiting composition
09/04/2003US20030165444 Lipochroman-6 as no-synthase inhibitor and uses
09/04/2003US20030165434 Delivery of polynucleotide agents to the central nervous system
09/04/2003US20030163931 Method for making homogeneous spray-dried soild amorphous drug dispersions utilizing modified spray-drying apparatus
09/04/2003CA2833470A1 Processes for preparing form 1 zd1839 polymorph
09/04/2003CA2702297A1 Novel crystalline forms of the anti-cancer compound zd1839
09/04/2003CA2513190A1 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
09/04/2003CA2479812A1 Glutaminyl based dpiv inhibitors
09/04/2003CA2477558A1 N-{5-[4-(4-methyl-piperazino-methyl)­-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
09/04/2003CA2477379A1 Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
09/04/2003CA2477350A1 Novel crystalline forms of the anti-cancer compound zd1839
09/04/2003CA2477347A1 Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases
09/04/2003CA2477328A1 Pyridyl tricyclic compounds as farnesyl protein transferase inhibitors and antitumor agents
09/04/2003CA2477283A1 Vascular therapeutic methods and compositions involving the reduction or prevention of c-jun mediated processes
09/04/2003CA2477253A1 Compositions and method for regulation of calcium-dependent signalling in brain
09/04/2003CA2477249A1 Novel type-1 cytokine receptor glm-r
09/04/2003CA2477231A1 Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy
09/04/2003CA2477218A1 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
09/04/2003CA2477111A1 Use of tyrosine kinase inhibitors for treating cns disorders
09/04/2003CA2477008A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003CA2477005A1 Use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase
09/04/2003CA2476994A1 Methods of extending corneal graft survival
09/04/2003CA2476782A1 Carboxyfullerenes and methods of use thereof
09/04/2003CA2476765A1 Methods of preventing or treating brain ischemia or brain injury
09/04/2003CA2476630A1 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof
09/04/2003CA2476571A1 Method for isolating ligands
09/04/2003CA2476518A1 Compositions and methods for the treatment of immune related diseases
09/04/2003CA2476316A1 Beta3-adrenergic receptor agonists
09/04/2003CA2476173A1 Arylsulfone derivatives
09/04/2003CA2475773A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
09/04/2003CA2475655A1 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
09/04/2003CA2475433A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(2-methoxyl)ethyl modifications
09/04/2003CA2475299A1 Thiazole derivatives as npy receptor antagonists
09/04/2003CA2475039A1 Macromolecular conjugates and processes for preparing same
09/04/2003CA2474805A1 Combinations of (a) an atp-competitive inhibitor of c-abl kinase activity with (b) two or more other antineoplastic agents
09/04/2003CA2473340A1 Formulations comprising a glp-1 compound and a delivery agent, and uses thereof
09/04/2003CA2451982A1 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
09/04/2003CA2444940A1 Process for the production of citalopram
09/03/2003EP1340821A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/03/2003EP1340820A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/03/2003EP1340818A1 Method and nucleic acids for the analysis of a colon cell proliferative disorder
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003EP1340752A1 Process for the production of semi synthetic statins via novel intermediates
09/03/2003EP1340744A2 Hiv protease inhibitors
09/03/2003EP1340509A1 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
09/03/2003EP1340500A1 Antidiabetic agents
09/03/2003EP1340499A1 Nootropic effect enhancer
09/03/2003EP1339878A2 Method for identifying modulators of transcription
09/03/2003EP1339847A2 Transforming growth factor-beta-related molecules and uses thereof
09/03/2003EP1339846A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339844A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339842A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339836A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
09/03/2003EP1339753A2 Percarboxylated polysaccharides, and a process for their preparation
09/03/2003EP1339749A1 Dextran-hemoglobin conjugates as blood substitutes
09/03/2003EP1339748A2 G-protein coupled receptors
09/03/2003EP1339719A1 Benzimidazole derivatives, preparation and therapeutic use thereof
09/03/2003EP1339716A1 Novel lactame-substituted pyrazolopyridine derivatives
09/03/2003EP1339715A2 Heterocyclic ether substituted imidazoquinolines
09/03/2003EP1339714A1 Novel sulfonamide-substituted pyrazolopyridine derivatives
09/03/2003EP1339711A1 Aminothiazoles and their use as adenosine receptor antagonists
09/03/2003EP1339710A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives
09/03/2003EP1339709A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
09/03/2003EP1339708A2 Indole-type inhibitors of p38 kinase
09/03/2003EP1339701A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
09/03/2003EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands
09/03/2003EP1339695A1 Farnesyltransferase inhibitors
09/03/2003EP1339692A1 Novel compounds for use as hiv protease inhibitors
09/03/2003EP1339691A1 Novel compounds
09/03/2003EP1339689A1 N-type calcium channel antagonists for the treatment of pain
09/03/2003EP1339687A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents
09/03/2003EP1339686A2 Cyanoguanidine prodrugs
09/03/2003EP1339685A2 Biphenylcarboxamides useful as lipid lowering agents
09/03/2003EP1339683A2 Estrogen receptor modulators
09/03/2003EP1339682A1 1,4-disubstituted piperazine derivatives useful as uro-selective $g(a)1-adrenoceptor blockers
09/03/2003EP1339680A1 Substituted oxindole derivatives as tyrosine kinase inhibitors
09/03/2003EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists
09/03/2003EP1339678A2 Ep4 receptor selective agonists in the treatment of osteoporosis
09/03/2003EP1339675A1 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003EP1339668A2 Bisubstituted carbocyclic cyclophilin binding compounds and theirus
09/03/2003EP1339663A2 Naphthalene derivatives
1 ... 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 ... 1564